Socialiya - Entertainment. Knowledge. Community.
New pancreatic cancer pill nearly doubles survival time in breakthrough trial

Daraxonrasib, a new pancreatic cancer drug targeting RAS mutations found in over 90% of cases, showe...

HEALTH NEWS May 18, 2026

New pancreatic cancer pill nearly doubles survival time in breakthrough trial

Daraxonrasib, a new pancreatic cancer drug targeting RAS mutations found in over 90% of cases, showed promising results in the first human trial led by the...

2 views 0 likes 0 comments
Share:
Daraxonrasib, a new pancreatic cancer drug targeting RAS mutations found in over 90% of cases, showed promising results in the first human trial led by the...

Author: Fox News

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya